National Center for Nanoscience and Technology
developed a DNA nanorobot loaded with the clotting protein thrombin and an AS1411 nucleolin-targeting aptamer, designed to open specifically at tumor vasculature and trigger local, targeted clotting — a landmark in-vivo demonstration of the aptamer-lock mechanism.
- Country
- China
dna-origami
nanorobot
cn
Coverage
| CN | EU | US | |
|---|---|---|---|
| foundries-design | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| DNA nanotechnology & DNA origami | foundries-design | High | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.